Par Drugs & Che.

  • Market Cap: Micro Cap
  • Industry: Chemicals & Petrochemicals
  • ISIN: INE04LG01015
  • NSEID: PAR
  • BSEID:
INR
82.47
-0.16 (-0.19%)
BSENSE

Apr 02

BSE+NSE Vol: 7616

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Standalone Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 6.88% vs 7.99% in Dec 2024

stock-summary

Standalone Net Profit

YoY Growth in nine months ended Dec 2025 is 4.70% vs 8.63% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is -8.03% vs 2.03% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is 33.33% vs 0.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024

Compare Nine Monthly Results Of Par Drugs & Che. With
Markets Mojo
Figures in Cr
Standalone Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
84.05
0
84.05
Other Operating Income
0.00
0.00
0.00
Total Operating income
84.05
0
84.05
Raw Material Cost
33.83
0
33.83
Purchase of Finished goods
0.00
0
0.00
(Increase) / Decrease In Stocks
0.62
0
0.62
Employee Cost
4.18
0
4.18
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
29.73
0.00
29.73
Total Expenditure (Excl Depreciation)
68.36
0
68.36
Operating Profit (PBDIT) excl Other Income
15.69
0.00
15.69
Other Income
3.65
0
3.65
Operating Profit (PBDIT)
19.34
0
19.34
Interest
0.08
0
0.08
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
19.26
0
19.26
Depreciation
2.77
0
2.77
Profit Before Tax
16.47
0
16.47
Tax
4.21
0
4.21
Provisions and contingencies
0.00
0
0.00
Profit After Tax
12.26
0
12.26
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
12.26
0
12.26
Equity Capital
12.30
0
12.30
Face Value
10.00
0
0.00
Reserves
98.83
0
98.83
Earnings per share (EPS)
0.00
0
0.00
Operating Profit Margin (Excl OI)
18.67%
0%
0.00
18.67%
Gross Profit Margin
22.91%
0%
0.00
22.91%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 84.05 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 6.88% vs 7.99% in Dec 2024

Nine Monthly - Standalone Net Profit
Standalone Net Profit 12.26 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 4.70% vs 8.63% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 15.69 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -8.03% vs 2.03% in Dec 2024

Nine Monthly - Interest
Interest 0.08 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 33.33% vs 0.00% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.67%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has fallen from Dec 2024